Designed for focused revision, Oswaal NEET resources include solved papers, concept guides and practice sets that support structured study and exam confidence.

Optimize your final preparation with a targeted 10-day study plan for CBSE Class 10 Board Exams 2026. Includes subject-wise revision tips, time ma ...

HBSE Class 12 Exam Datesheet: The Board of School Education Haryana (HBSE) has officially released the Class 12 (Senior Secondary) examination date sheet for the 2025-26 session, the exam is starting ...

Brainrot Evolution Update 39 rolled out today, January 17, bringing in new events, rewards, weathers, and more. The update has also introduced various new quests to the game, which can be completed ...

Dispatch Bio, a biotech company engineering a universal treatment across solid tumors leveraging its first-in-class Flare platform, today announced that the U.S. Food and Drug Administration (FDA) has ...

With the Class 12 board examinations approaching, the CBSE Biology sample paper offers students a clear guide to the exam pattern, marking scheme and key topics ahead of the March 27 test. The Central ...

Candidates can click on the link provided here to download the official notice related to the CBSE Class 10th and 12th rescheduling of exams.Schools have been instructed to communicate the revised ...

Chicago-based Amphix Bio has raised $12.5 million in seed funding to advance its experimental paralysis-reversing drug toward human trials, the Northwestern University spinout announced today. The ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Generation Bio, which once ...

Dec 15 (Reuters) - Private biotech company Dren Bio has entered into a strategic collaboration with French drugmaker Sanofi (SASY.PA), opens new tab to develop therapies for autoimmune diseases in a ...

KALA BIO, Inc. (NASDAQ: KALA) shares jumped 22.16% to $1.13 in after-hours trading on Wednesday. Check out the current price of KALA stock here. Securities and Exchange Commission filings indicate ...

Light chain amyloidosis is not cancer, but cancer drugs are this rare disease’s standard of care. The patient need for new treatment options has sparked R&D efforts at biotech and big pharmaceutical ...